The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
Yoo Jin Shim, Aeran Seol, Dayong Lee, Seul Ki Kim, Jung Ryeol Lee, Byung Chul Jee, Chang Suk Suh, Seok Hyun Kim
Obstet Gynecol Sci. 2018;61(2):242-246.   Published online 2018 Feb 28     DOI:
Citations to this article as recorded by Crossref logo
Ovarian stimulation for fertility preservation in women with cancer: A systematic review and meta-analysis comparing random and conventional starts
Vinita M. Alexander, Caitlin E. Martin, Allison P. Schelble, Alexandra B. Laufer, Angela Hardi, Laurie J. McKenzie, Heather S. Hipp, Jennifer F. Kawwass, Jessica B. Spencer, Emily S. Jungheim
Journal of Gynecology Obstetrics and Human Reproduction.2021; 50(8): 102080.     CrossRef
Controlled ovarian hyperstimulation for fertility preservation in women with breast cancer: Practical issues
So Yun Park, Kyungah Jeong, Eun Hye Cho, Hye Won Chung
Clinical and Experimental Reproductive Medicine.2021; 48(1): 1.     CrossRef
IVF stimulation in pregnancy: lessons to be learned with implications for the luteal phase start IVF cycle
Naama Al Mamari, Weon-Yong Son, Melissa Pansera, Ahmed Badeghiesh, Michael H. Dahan
Journal of Assisted Reproduction and Genetics.2020; 37(2): 487.     CrossRef
Aromatase Inhibitors for Ovarian Stimulation in Patients with Breast Cancer
Esteban Ferreiro , Belén López de Uralde , Rita Abreu , Juan A García-Velasco , Elkin Muñoz
Current Drug Targets.2020; 21(9): 910.     CrossRef